<?xml version="1.0" encoding="UTF-8"?>
<p>Emtricitabine (2',3'-deoxy-5-fluoro-3'-thiacytidine, FTC) is structurally similar to lamivudine and was licensed by the FDA in 2003 [
 <xref rid="B40-vetsci-02-00456" ref-type="bibr">40</xref>]. 
 <italic>In vitro</italic>, antiviral efficacy has been demonstrated against FIV [
 <xref rid="B17-vetsci-02-00456" ref-type="bibr">17</xref>,
 <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
 <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
 <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>], but to date there have been no 
 <italic>in vivo</italic> studies in FIV-infected cats.
</p>
